reform research tirzepatide Tirz 15 mg | Dual Incretin Agonist Tirzepatide Research: Comprehensive Review of

Texas removed the in-person visit requirement in 2017

A significant publication bias was detected for MACE (Eggers p = 0.013)

*Correspondence: Margarida Castro-Caldas, [email protected] This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Roche initiated two Phase 3 trials (ENITH-1 and ENITH-2) in Q1 2026 and plans a combination study with petrelintide, an amylin analog, in mid-2026